You just read:

Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies

News provided by

Generex Biotechnology Corporation

Jan 30, 2013, 09:30 EST